Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs
Sep 27, 2023 17:00 HKT |  |
|
A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK
Sep 25, 2023 12:45 HKT |  |
|
Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
Sep 19, 2023 21:00 HKT |  |
|
CGFNS Appoints New Chief Technology Officer to Lead its Digital Transformation
Sep 15, 2023 09:00 HKT |  |
|
Vegan Cats Challenge Carnivorous Expectations
Sep 15, 2023 08:00 HKT |  |
|
Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK
Sep 13, 2023 11:30 HKT | |
|
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Sep 12, 2023 20:00 HKT |  |
|
SinoMab's IND Application of SM17 has once again Received Approval from NAMP
Sep 12, 2023 09:48 HKT |  |
|
Q&M Dental Group Sets the Gold Standard for Best Investor Relations at Singapore Corporate Awards
Sep 11, 2023 10:00 HKT |  |
|
UroViu Corporation Appoints Ali Amiri as New President and Chief Operating Officer
Sep 06, 2023 21:00 HKT |  |
|
Peijia Medical Announces 2023 Interim Results
Aug 31, 2023 22:47 HKT | |
|
Sihuan Pharmaceutical (0460.HK) Announces 2023 Interim Results, Revenue amounted to RMB1,055.7 million
Aug 31, 2023 13:50 HKT | |
|
Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals
Aug 29, 2023 13:00 HKT |  |
|
Net Profit of Kingworld Medicines Increased By 55.8%
Aug 28, 2023 21:56 HKT | |
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
Aug 28, 2023 19:30 HKT |  |
|
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results
Aug 25, 2023 19:12 HKT |  |
|
Hua Medicine Announces 2023 Interim Results
Aug 25, 2023 18:20 HKT |  |
|
Ocumension Therapeutics Announces 2023 Interim Results
Aug 24, 2023 23:35 HKT |  |
|
Universal Medical Announces 2023 Interim Results
Aug 24, 2023 20:30 HKT |  |
|
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
Aug 24, 2023 20:00 HKT |  |
|